Analysis of Omnimmune Holdings, Inc. (OMMH)
Omnimmune Holdings, Inc. (OMMH) has been trading at a consistent price of 0.00010 for the past few days. The Relative Strength Index (RSI) indicator shows a value of 51.85, indicating a neutral position. However, the Moving Average Convergence Divergence (MACD) indicator is not available for analysis, suggesting a lack of trend confirmation.
It's worth noting that the Moving Average (MA) indicator is consistent with the closing price, indicating stability in the short term. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are also in line with the current price.
Overall, based on the available data, OMMH appears to be trading in a tight range with no clear trend direction. Further analysis with additional indicators and market context would be beneficial to make a more informed investment decision.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. The company has been consistently paying interest and income taxes each year.
3. The end cash position has been varying, reaching its peak in 2020.
4. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
5. Investing activities indicate significant investments in the sale and purchase of investments, with fluctuations in capital expenditures.
6. Operating activities reflect the company's net income, depreciation, and operating cash flow, which have been relatively stable over the years.
7. Stock-based compensation is a notable component of the company's operating activities.
8. Overall, the company's cash flow statement shows a mix of stable and fluctuating financial activities over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the previous year's EPS figures, indicating optimism among analysts regarding the company's performance.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates a healthy growth trajectory for the company in the near future, albeit at a slightly slower pace than in the past.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, suggesting that there may be potential for the security to increase in value according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 15.31 billion float shares and 94.31 million shares shorted. The average 10-day trading volume is 52.90 million shares, while the average 90-day trading volume is 62.82 million shares. The company has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.55% held by institutions.
Valuation metrics show a PEG ratio of 26.21, forward PE of 26.21, trailing PE of 29.43, and an enterprise value of $2.95 trillion. The price to book ratio is 39.18, price to sales ratio is 7.62, enterprise to EBITDA ratio is 22.75, and enterprise to revenue ratio is 7.73. The market capitalization is $2.91 trillion.
The stock price summary includes a beta of 1.26, 50-day moving average of $173.69, 200-day moving average of $180.79, a 52-week low of $164.08, a 52-week high of $199.62, and a 52-week change of 8.25%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a need for cost management or pricing strategies to maintain profitability.
3. The gross profit margin has fluctuated slightly but remained relatively stable over the years.
4. Operating income has shown an increasing trend, reaching $114.3 billion in 2023.
5. Net income has also been on the rise, reaching $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to maintain a consistent number of outstanding shares, which is important for investors.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated, with the highest value in 2019 at $162.8 billion and the lowest in 2023 at $135.4 billion.
3. Non-current assets have shown an increasing trend, reaching $217.4 billion in 2023.
4. Total liabilities have also been increasing, from $255.4 billion in 2018 to $290.4 billion in 2023.
5. Shareholders' equity has shown fluctuations but has generally increased from $107.1 billion in 2018 to $62.1 billion in 2023.
6. The company has been relying more on non-current assets to support its growth, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its growth through a combination of liabilities and shareholders' equity, with both showing an increasing trend over the years.